Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

NCT01371474 · clinicaltrials.gov ↗
COMPLETED
Status
1483
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline